CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 4 Other disposition 10% owner disposed of 913,659 shares (other)
- 8-K Event Agreement ended
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale See Remarks sold 381 shares at $9.03 ($3,440)
- 4 Open-market sale See Remarks sold 445 shares at $10.68 ($4,753)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale See Remarks sold 432 shares at $10.94 ($4,726)
- 4 Open-market sale See Remarks sold 365 shares at $10.98 ($4,008)
- 4/A Insider Changes in Ownership
- 4 Open-market sale See Remarks sold 431 shares at $11.01 ($4,745)
- 8-K Event Other events
- 4 Open-market sale See Remarks sold 366 shares at $13.20 ($4,831)
- 4 Open-market sale See Remarks sold 427 shares at $13.27 ($5,666)
- 4 Open-market sale See Remarks sold 363 shares at $13.91 ($5,049)
- 4 Open-market sale See Remarks sold 440 shares at $13.92 ($6,125)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale See Remarks sold 381 shares at $13.55 ($5,163)
- 4 Open-market sale See Remarks sold 399 shares at $15.01 ($5,989)
Page 16 of 20 · 384 filings